A trial to learn if AZD9829 is safe and works alone and in combination with other treatments for participants with certain blood cancers.
D9470C00001
Phase 1 other active
Quick answer
A trial to learn if AZD9829 is safe and works alone and in combination with other treatments for participants with certain blood cancers. for CD123-Positive Hematological Malignancies: Module 1 focuses on R/R Acute Myeloid Leukemia and R/R Myelodysplastic Syndrome. is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- CD123-Positive Hematological Malignancies: Module 1 focuses on R/R Acute Myeloid Leukemia and R/R Myelodysplastic Syndrome.
- Phase
- Phase 1
- Modality
- other
- Status
- active